Ethyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 1g

((2S,4R)-4-AMINOPYRROLIDIN-2-YL)METHANOL 2HCL, 95.0%, 10mg

2-Chlorothiophene-3-carboxylic acid, 95.0%, 1g

Ethyl 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxylate, 95.0%, 5g

tert-butyl N-[2-amino-2-(4-fluorophenyl)ethyl]carbamate, 95.0%, 1g

(4-(5-Oxopyrazolidin-3-yl)phenyl)boronic acid, 97%, 100mg

ethyl 2-(3,5-dichloropyrazin-2-yl)-2-oxoacetate, 95%, 250mg

Methyl (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylate (2S,3S)-2,3-bis(benzoyloxy)succinate, 97%, 250mg

N-(1,3,4-Thiadiazol-2-yl)nicotinamide hydrochloride, 97%, 1g

(4R)-2-(2-hydroxyphenyl)-1,3-thiazolidine-4-carboxylic acid, 95%, 1g

Disposable samplers DispoLance for solids, Non-sterile, 300 mm, 10 pieces

3-OXO-4-ANDROSTENE-17�-CARBOXYLIc acid, 98.0%, 100g

2-(2-Aminothiazol-5-yl)ethanol, 95.0%, 5g